Results 151 to 160 of about 183,686 (358)

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

Arthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen, Duanping Liao, Judith A. James, Joel M. Guthridge, Cristina Arriens, Diane Kamen, Mariko Ishimori, Daniel J. Wallace, Christopher Striebich, Sonali Narain, Benjamin F. Chong, Fan He, Eric W. Schaefer, Vernon M. Chinchilli, David R. Karp   +14 more
wiley   +1 more source

NETs - as predictors and targets of supportive therapy for cancer treatment

Frontiers in Immunology
NETs are network-like structures consisting mainly of DNA and various proteins released by neutrophils physiologically in response to pathogens. Moreover, according to recent reports, NETs also play an important role in carcinogenesis.
Maria-Laura Morawiec, Robert Kubina, Robert Kubina, Ewa Jabłońska, Wioletta Ratajczak-Wrona, Sebastian Stępień, Maciej Gołębski, Aleksandra Mielczarek-Palacz   +7 more
doaj   +1 more source

Severe Acute Respiratory Syndrome Coronavirus 2 Serology in Asymptomatic Healthcare Professionals: Preliminary Experience of a Tertiary Italian Academic Center [PDF]

, 2020
Francesca Tosato, Michela Pelloso, Nicoletta Gallo, Chiara Giraudo, G Llanaj, Chiara Cosma, C Pozzato, Andrea Padoan, Daniele Donato, Mario Plebani   +9 more
openalex   +1 more source

P239 Clinical outcomes of syphilis in HIV-negative and HIV-positive MSM: Occurrence of repeat syphilis episodes and non-treponemal serology responses [PDF]

, 2021
R Sprenger, M Schim-van der Loeff, Henry J.C. de Vries   +2 more
openalex   +1 more source

Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation

EClinicalMedicine, 2020
K. Oved, L. Olmer, Y. Shemer-Avni, T. Wolf, L. Supino-Rosin, G. Prajgrod, Y. Shenhar, Irina Payorsky, Y. Cohen, Y. Kohn, V. Indenbaum, R. Lazar, Valeria Geylis, Michal Tepperberg Oikawa, E. Shinar, Evgeniy Stoyanov, L. Keinan-Boker, R. Bassal, S. Reicher, Ruti Yishai, A. Bar‐Chaim, R. Doolman, Y. Reiter, E. Mendelson, Z. Livneh, L. Freedman, Y. Lustig   +26 more
semanticscholar   +1 more source

Mechanistic Consequences of Piezo1 Gain‐of‐Function Variants for Decreased Red Cell Survival in Hereditary Xerocytosis

American Journal of Hematology, EarlyView.
Asya Makhro, Rick Huisjes, Elena Seiler, Min Qiao, Marije Bartels, Inga Hegemann, Patrick Eppenberger, Nicole Bender, Isabel Dorn, Anna Bogdanova, Richard van Wijk, Lars Kaestner   +11 more
wiley   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

A Report of a Rare Case of a Solitary Ring-Enhancing Lesion in a Patient With Positive Toxoplasma Serology [PDF]

Brendan Chernicki, Beatriz Cobo Dominguez, Michael C Huzior, Jessica Caushi, Catalina Romo Aguirre, Ravi J. Chokshi   +5 more
openalex   +1 more source

Efficacy of Telitacicept in Childhood‐Onset Systemic Lupus Erythematosus: A Prospective Multicenter Cohort Study With Inverse Probability of Treatment Weighting –Adjusted Comparison to a Historical Control Group Treated With Belimumab

Arthritis &Rheumatology, EarlyView.
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo, Shu Su, Jingyue Liu, Junyu Lin, Jin Song, Zongwen Chen, Yuanyuan Peng, Lijun Jiang, Meng Jia, Li Wang, Xinhui Jiang, Wei Zhang, Zanhua Rong, Bo Zhao, Yajun Wang, Xuemei Tang   +15 more
wiley   +1 more source